Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles - Investor's Business Daily
Source:Investor's Business Daily
Crinetics stock nearly doubled Tuesday after Vertex pledged $10 billion to buy the endocrinology-focused biotech.
Crinetics stock nearly doubled Tuesday after Vertex pledged $10 billion to buy the endocrinology-focused biotech.